Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

The lab's 25 or so full-time employees were put on administrative leave on March 27, forcing it to shut down operations.

RSV, meningococcal, and chikungunya vaccine recommendations from the previous ACIP panel are now official policy.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Lubbock Public Health is facing potential federal cuts to their budget, including a proposed 50% reduction in CDC funding, as ...

The World Health Organisation’s Global TB <a href=" estimates Lesotho’s TB incidence at 664 cases per 100,000 people. About half of TB patients are also HIV-positive ...

"What are sometimes called superbugs — microbes resistant to every available drug — are not merely the stuff of nightmares.

People who have had direct contact with a person with tuberculosis might be eligible for a free limited latent tuberculosis infection (LTBI) test, the Centers for Disease Control (CDC) said yesterday ...

For example, one clinical trial sponsored by the National Institutes of Health and the CDC showed that TB infection can be successfully treated with 12 weeks of a once-weekly treatment called 3HP ...

In 1900, TB was the leading cause of death in the U.S, killing 194 of every 100,000 persons, according to the CDC.

The 2015-17 outbreak cited by the CDC was linked to homeless shelters in Georgia. The CDC said more than 170 cases of TB disease and more than 400 cases of inactive TB were detected. The 2021 ...

TB germs are not spread by shaking someone's hand, kissing, sharing food or drinks, or touching toilet seats, per the CDC. People with latent TB are not contagious and cannot spread the infection ...